• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Reyataz (atazanavir sulfate) capsules

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – January 2010

 

Summary View

 

DRUG INTERACTIONS

  • The results of a drug-drug interaction study of atazanavir with ritonavir and rifabutin and the results of an interaction study from published literature regarding atazanavir with or without ritonavir and buprenorphine were added

PATIENT PACKAGE INSERT

What important information should I know about taking Reyataz with other medicines?
  • The following medicines may require your healthcare provider to monitor your therapy more closely: rifabutin and buprenorphine